Our US based client has developed a 100% efficient anti-MRSA wash and is now looking to identify both regional and global distribution partners.

MRSA continues to pose a public health threat, in the US alone 95, 000 cases are identified per year causing 18, 000 deaths. The MRSA market is now worth US$4.2 billion per year.

Developing a portfolio of anti-MRSA products, our US based clients have manufactured a new FDA approved product that is 100% efficient in killing MRSA bacteria without the use of antibiotics.

Fully patented and ready for distribution the topically administered wash does not interact with any drugs and causes no side-effects for users.

 

Early Stage

Our clients are seeking both regional and global partners to distribute their wash, ideally to hospitals, medical environments, doctors' surgeries, etc.